Physician profile
Bryan M Purdy
NPI 1659582310
$12,259.20
in general payments reported to CMS, 2019-2025
14 companies · $36.04 in 2025
The $36.04 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2021: $60.56 · 2022: $74.53 · 2023: $261 · 2024: $63.24 · 2025: $36.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $11,283.97 | 2019 | |
| Abbott Laboratories | $190.09 | 2019 | |
| Edwards Lifesciences Corporation | $189.31 | 2019-2023 | Hemosphere |
| Karl Storz Endoscopy-America | $146.41 | 2019-2023 | N.A. |
| Merck Sharp & Dohme LLC | $82.90 | 2021-2023 | Bridion |
| Becton, Dickinson and Company | $79.03 | 2023 | Phasix Mesh |
| Chiesi USA, INC. | $62.39 | 2019 | |
| Vyaire Medical, INC. | $52.36 | 2022-2023 | |
| Heron Therapeutics, INC. | $38.23 | 2023-2024 | Aponvie |
| Octapharma USA, INC. | $36.04 | 2025 | Fibryga |
| Vertex Pharmaceuticals Incorporated | $31.93 | 2024 | |
| Boston Scientific Corporation | $25.97 | 2019 | |
| Itamar Medical INC | $25.46 | 2023 | Watchpatone |
| Pajunk Medical Systems, LP | $15.11 | 2024 | E-Cath Plus Acc. Tsui |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Purdy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.